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Abstract: Failure to initiate or intensify therapy according to evidence-based guidelines is 
increasingly being acknowledged as a phenomenon that contributes to inadequate management 
of chronic conditions, and is referred to as clinical inertia. However, the number and complexity 
of factors associated with the clinical reasoning that underlies the decision-making processes in 
medicine calls for a critical examination of the consistency of the concept. Indeed, in the absence 
of information on and justification of treatment decisions that were made, clinical inertia may 
be only apparent, and actually reflect good clinical practice. This integrative review seeks to 
address the factors generally associated with clinical inaction, in order to better delineate the 
concept of true clinical inertia.
Keywords: clinical inertia, evidence-based medicine, clinical decision, integrative review, 
concept clarification, physician adherence to guidelines
Introduction
Failure to treat to target, or prescription that is not concordant with guidelines, is 
increasingly being referred to as clinical inertia. Phillips et al first coined the term, 
which they defined as a failure to initiate or intensify therapy when indicated or a 
failure to act despite recognition of the problem.1
Although clinical inertia is a major factor that contributes to inadequate manage-
ment of chronic conditions (diabetes, hypertension, lipid disorders),2,3 its actual clinical 
impact remains unclear.4 It has been suggested that clinical inertia related to the man-
agement of diabetes, hypertension, and lipid disorders may contribute to up to 80% of 
heart attacks and strokes.5 As it is associated with poor control of risk factors known to 
lead to long-term health problems, clinical inertia has an economic impact in terms of 
national health care expenditure alongside medical consequences for patients.6–8
Studies on clinical inertia are most relevant in the context of asymptomatic chronic 
conditions, where therapeutic decisions are influenced by assessing evidence-based 
clinical outcomes rather than by monitoring symptoms or patients’ complaints.  Clinical 
inertia arises in the context of evidence-based practices, and may be identified if three 
conditions are precisely defined: recognized clinical outcomes (goals or targets); 
a recommended therapy that can be measured; and a window of time appropriate for 
initiation or intensification of treatment.2,5 It has been argued, however, that such stan-
dardized definitions of clinical inertia based on target, time frame, and the decision to 
intensify therapy (or not) are not sufficient to determine whether individual decisions 
to increase, decrease, or maintain therapy might be appropriate for a patient.9,10 Indeed, 
in order to adequately assess clinical inertia, it is necessary to define intermediate 
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outcomes that incorporate information on and justification 
of decisions relating to treatment.11 In the absence of such 
information, clinical inertia may be only apparent, and actu-
ally reflect good clinical practice.9
In order to better disentangle true clinical inertia from 
apparent clinical inertia, it is necessary to understand which 
modifiable and nonmodifiable factors underlie true clinical 
inertia. The identification of such factors is a necessary step 
toward developing strategies to further improve adherence 
of providers to guidelines. O’Connor et al postulate three 
classes of factors leading to clinical inertia, ie, factors related 
to providers, patients, and the system, with an estimated 
relative contribution of 50%, 30%, and 20%,2 respectively. 
Other authors report up to 75% provider-related factors.4 The 
provider-related factors that were initially defined by Phillips 
et al1 are still assumed to be the most common contributors 
to clinical inertia,2,5,12 ie, providers overestimating the care 
they offer, providers’ use of “soft” reasons to avoid therapy, 
and providers’ lack of education, training, or organization for 
achieving therapeutic goals. However, it has been claimed 
that evidence regarding factors of clinical inertia is still poor 
due to a lack of well conducted studies.13
Moreover, we argue that the list of factors mentioned 
above is of little help in practice, because it does not take 
sufficient account of the considerable challenge that faces 
providers, since they have to make decisions in the context 
of uncertainty which is inherent in the practice of medicine.14 
Practitioners need to be helped, in practice, to overcome true 
clinical inertia rather than systematically blamed for inaction 
(the latter being occasionally appropriate). As a first step 
toward elaborating solutions to help practitioners overcome 
true clinical inertia, we attempted through careful examina-
tion of the literature to identify and review factors that have 
been associated with clinical inertia since the term was first 
coined in 2001.
Materials and methods
Data sources and study selection
A preliminary search was done to determine the volume 
and distribution of literature between 2001 and July 2011 
by searching PubMed with keywords (“clinical inertia” OR 
“therapeutic inertia” OR “physician inertia” OR “diagnostic 
inertia”), excluding comments (publication type). A total of 
174 articles were published between 2001 and 2011, with about 
half of the citations published between 2009 and 2011.
The full text of each of the 174 publications retrieved from 
PubMed was individually reviewed as a first step toward inte-
grating knowledge about factors associated with clinical  inertia. 
The results of our integrative review, presented hereafter, are 
based on a systematic process of thematic analysis, which 
was performed on a sample of 40 articles selected to provide 
a balanced selection of reports on the topic of clinical inertia. 
This selection was based on the following criteria: to reflect 
the range of diseases affected; to achieve an even selection of 
articles from across the whole time frame (2001–2011) while 
avoiding selection of many repetitive studies from the period 
2009–2011; to avoid overrepresentation from one particular 
group of writers; and to provide a representative selection 
covering the different therapeutic domains.
Data extraction
All information relevant to our research objective (ie, to 
identify the various factors associated with clinical inertia) 
was extracted from each publication and analyzed induc-
tively according to qualitative methods of thematic coding 
and  categorization.15 The initial coding was a collaboration 
between two researchers (IA and PJ) who independently coded 
a selection of manuscripts in order to develop significant cat-
egories from the data itself, rather than from predetermined 
theories or hypotheses. The emerging thematic categories were 
discussed until a consensus was reached, keeping in mind that 
our findings should have a potential for clinical discussion and 
application. In other words, we deliberately looked at clinical 
inertia as a challenge for, rather than a failure of, health care 
providers. As a result of this inductive process of analysis 
and discussion, four main thematic categories were created 
and applied to all selected articles:  providers’ knowledge of 
and attitudes toward evidence-based guidelines; providers’ 
own clinical judgment; providers’ awareness of patients’ 
attitudes, behaviors, and preferences; and providers’ ability 
to make decisions in specific clinical contexts. This part of 
the coding was performed by IA. In order to ensure reliability 
of our results, this analysis was subsequently cross-checked 
by PJ. The full list of thematic categories and subcategories 
is presented in Table 1.
Results
Our results are presented hereafter according to the list of 
themes that were inductively created from the material and 
that are presented in Table 1.
Providers’ knowledge of and attitudes 
toward evidence-based guidelines
(In)sufficient knowledge of guidelines
Lack of awareness of evidence-based goals of care, or lack 
of familiarity with guidelines, has been reported as a major, 
Advances in Medical Education and Practice 2014:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
143
Factors associated with clinical inertia
Table 1 Summary of factors contributing to clinical inertia
Providers’ knowledge  
of and attitudes  
toward evidence- 
based guidelines
Providers’ own  
clinical judgment  
and experience in relation  
with specific situations
Providers’ awareness  
of patient attitudes,  
behaviors and  
preferences
Providers’ ability to make  
the appropriate decision  
within a given clinical and  
organizational context
(In)sufficient knowledge  
of guidelines
Patients’ characteristics
Patients’ medical factors  
and medical history
Providers’ acknowledgment  
of patient preferences
Patient adherence
Patient health literacy  
and empowerment
Reluctance to or difficulty 
associated with change
Clinical uncertainty
Limited time to handle a number  
of competing demands
Organizational and structural factors
(Dis)agreement with  
known guidelines
(Dis)agreement with  
applicability of guidelines
sometimes self-reported, contributor to clinical inertia.5,16 
Lack of familiarity with guidelines may have to do with the 
large number of guidelines, and the time required to keep 
these accurately updated.17
(Dis)agreement with known guidelines
Some limitations are inherent to the guidelines themselves, 
which may be written in an ambiguous way that makes 
uniform application by different practitioners difficult.17 
However, physicians may also deviate from these guidelines 
because of disagreement with or distrust of the evidence 
underpinning goals of care.8,16,18,19
(Dis)agreement with applicability of guidelines
Disagreement may occur not only with the guidelines them-
selves, but also with their applicability to certain groups of 
patients.17 According to Teles et al, “there may be quite a 
difference between understanding the evidence and using 
it”.20 Indeed, patients’ individual characteristics impact on 
physicians’ assessment of the relevance of specific  guidelines. 
Elderly patients, patients with comorbidities, and those with 
affective or substance abuse problems are likely to be treated 
differently.2,17,18,21 The main reason for clinical inertia in such 
subgroups is uncertainty regarding the appropriateness of 
existing guidelines.22
Providers’ own clinical judgment  
and experience
Providers’ attitude toward the appropriateness of applying 
specific guidelines for particular patients is influenced by their 
own clinical judgment and experience, and individual patients’ 
sociodemographic characteristics and medical history.23
Patient characteristics
Old age in patients may be considered a major factor in clini-
cal inertia over a broad spectrum of chronic conditions.4,24,25 
More specifically, in the management of hypertension, 
fear of the consequences of treating an elderly person’s 
 hypertension may outweigh the perception of the risks 
associated with hypertension. Existing guidelines may 
therefore be perceived as having limited applicability.18,19 
The same diff iculty exists in the f ield of diabetes.26 
 Moreover, gender disparities are reported by some, with 
women more likely to suffer than men as a result of clini-
cal inertia with regard to the prevention of cardiovascular 
disease.27,28 However, other studies report no evidence 
of gender issues in relation to clinical inertia,29 so the 
evidence is inconsistent. Last but not least, limited reim-
bursement, socioeconomic and cultural disparity in terms 
of affordability or acceptability of a prescribed treatment, 
or lack of health care availability for underserved popula-
tions are all significant barriers to treatment modification 
according to guidelines.6,17,18
Patients’ medical history
Several authors report that there might be no treatment 
intensification when the assessed values lie close to the 
desired threshold,8,10,11,21 especially if patients are already 
on therapy, and more time is needed to assess the effects 
of existing therapy.21 The presence of comorbidities raises 
uncertainty as to whether existing guidelines are system-
atically  appropriate. In that regard, the management of 
hypertension in diabetic patients appears to be particularly 
problematic.10,30 On the one hand, due to the presence of 
more than one concomitant disease, one particular comor-
bid condition may appear as relatively less important.31 On 
the other hand, the sheer number of different medication 
techniques involved in treating several pathologies may 
be a barrier to further intensification of care.6,11,24,28–30,32,33 
Reluctance to modify therapy may then be ascribed to a lack 
of alternative treatments, concern about potential adverse 
effects, and/or drug interactions.18,22
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Providers’ awareness of patients’ 
attitudes, behaviors, and preferences
Medical decisions are further influenced by the quality of the 
patient-provider relationship, with the providers’ capacity 
to be more or less patient-centered on the one hand and the 
patients’ disposition regarding adherence, health literacy, 
and self-empowerment on the other.
Providers’ acknowledgment of patient preferences
Patients’ preferences may include concerns regarding 
the importance of following clinical practice guidelines. 
Indeed, some patients would rather opt for a lifestyle 
change prior to medication.18 In the field of diabetes, the 
fear of weight gain and hypoglycemia is a major concern 
that may impact on patients’ acceptance of treatment, and 
in turn influence the physician’s decisions to intensify 
therapy.22
Patient adherence
Established or suspected patient nonadherence may predis-
pose providers to expect a negative result, thereby contrib-
uting to clinical inertia. Moreover, providers may feel that 
they are unable to overcome some patients’ behaviors, such 
as smoking or eating disorders in obesity.17 Patient nonad-
herence and clinical inertia on the part of the physician are 
equally rooted in complex and intertwined factors related to 
the physician, the patient, the treatment, and the health care 
system, and both may be seen as reflecting the quality of 
some aspects of the patient-provider relationship that need 
to be improved.34
Patient health literacy and empowerment
Patients who are more educated about their condition and the 
health risks inherent to it might be less likely to experience 
clinical inertia.30 On the one hand, less educated patients 
might lack the necessary motivation for sufficient manage-
ment of asymptomatic problems.1 On the other hand, better 
educated patients are more likely to request more from their 
health care providers, and therefore experience less clinical 
inertia.35
Providers’ ability to make an appropriate 
decision in a given clinical and 
organizational context
The importance of the decision-making process involved 
in clinical inertia has been outlined by several authors,2,5 
with four main factors identified as having a major impact 
on the providers’ decision-making ability, ie, providers’ 
reluctance to change, uncertainty regarding the assessment 
of biological outcomes, competing demands, and organi-
zational factors.
Reluctance or difficulty to change is a factor often asso-
ciated with clinical inertia.17,19 It may explain what other 
authors following Phillips et al1 have named “overestimation 
of current care”5,16 or “complacency with borderline values”.4 
It has to do with the subjective perception of providers that 
the care provided is sufficient.8
Uncertainty may arise in treating asymptomatic patients 
when the validity of clinical values is not credible enough. 
Successful implementation of clinical guidelines is related 
to the credibility of clinical values.4,30 However, physicians 
sometimes lack accurate information on which to base their 
decisions. For instance, clinical uncertainty regarding actual 
blood pressure17,18 or updated HbA1c values36 are common 
phenomena.
Limited time to handle a number of competing demands 
is another important factor that impacts on physicians’ 
decision-making capacity.6,22,37,38 The treatment of hyper-
tension, for instance, may be placed at a lower level of 
priority when practitioners are faced with a number of 
other needs.17
Moreover, organizational and structural factors as well 
as specific, sometimes stressful, working conditions that 
are linked to different contexts of care play a role in clinical 
practice.11,39 Several authors looked at possible differences 
between general practice and hospital-based care. In the field 
of hypertension, one study found that treatment in primary 
care was a risk factor for clinical inertia.24 Regarding the 
treatment of diabetes, the study reported by Goderis et al40 in 
Belgium made it clear that factors related to the health care 
system are strongly involved in differences between primary 
care level and specialized care: “(In Belgium), initiation of 
insulin is particularly counteracted by the dichotomy between 
primary care and endocrinologists installed by the reimburse-
ment system, limiting reimbursement of diabetes education 
and self home blood glucose monitoring materials to special-
ized diabetes centers. This skewed reimbursement prevents 
many general practitioners from timely initiating insulin, in 
an already insulin-hostile population.” This was found to be 
true in other contexts as well, when policies restrict formu-
lary access to newer, more expensive  medication.33 How-
ever, clinical inertia in relation to the treatment of diabetes 
has been clearly documented in hospital settings as well.41 
Rather than opposing primary and specialist care, there have 
been suggestions that it is precisely “the lack of shared care 
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organization between the specialist and primary care” that 
may contribute to clinical inertia.22 Moreover, rather than 
simply distinguishing between different levels of care, the 
lack of availability of multidisciplinary and/or team-based 
care, which often characterizes general practice, has been 
cited by several authors as an important factor that might be 
associated with clinical inertia.8,17,25,42
Discussion and conclusion
At the heart of evidence-based medicine is the providers’ 
capacity to integrate individual clinical expertise with the 
best available clinical evidence from systematic research.43 
Our review shows that a large number of potential factors are 
associated with clinical inertia in the broader sense. However, 
there is little evidence of any one or combination of factors 
that might be considered the primary determinant of clinical 
inertia. Taking into account the definition of evidence-based 
practice, we argue that our results further show that the fac-
tors generally associated with clinical inertia are not specific 
enough to distinguish appropriate inaction from true clinical 
inertia. Given the growing importance attached to the phe-
nomenon of clinical inertia (174 articles published between 
2001 and 2011, of which about half were published between 
2009 and 2011), more research is needed to further examine 
the nature of true clinical inertia and establish the prevalence 
and weight of the various factors that contribute to it, as well 
as to better understand possible interactions between factors 
that might contribute simultaneously to clinical inertia.
Clinical inertia often manifests itself within complex clinical 
situations, eg, patients with comorbidities, younger or elderly 
patients, patients who are already on a number of medications, 
and patients of lower socioeconomic status. In such situations, 
inaction to some extent is sometimes more appropriate than 
intensifying treatment. Rather than simply representing a lack of 
awareness or genuine disagreement with existing guidelines, so-
called clinical inertia might reflect conflicting or unaddressed 
issues with the applicability of guidelines to specific groups of 
patients where evidence is lacking. It has been recently sug-
gested that individualizing targets and tactics may be clinically 
important for high-risk patients with type 2 diabetes.44 It is 
assumed that clinical inertia is more likely to occur in patients 
who are less active and empowered, given that better educated 
patients tend to request more from health care providers and 
cope better with the challenge of developing the necessary 
motivation and skill to adhere to medical recommendations. 
Self-management support by intervening in the health educa-
tion of patients is therefore a potentially important strategy 
to help overcome clinical inertia.34,37 Yet, at the same time, 
better empowered patients might be able to express different 
preferences, eg, attempting lifestyle changes prior to starting 
on medication. Whether the decision to not initiate treatment 
under such circumstances should be labeled as clinical inertia 
is a matter for debate. Studies investigating the phenomenon 
of clinical inertia should systematically incorporate an analysis 
of the reasoning processes underlying the decisions that clini-
cians make.
True clinical inertia corresponds to medical malpractice, 
and strategies need to be established in order to help provid-
ers recognize and overcome it. Possible strategies include the 
development of regular reminders and decision support tools. 
Indeed, performance audit and feedback, including bench-
marking when feasible and acceptable, are very important 
issues in efforts to improve quality of care.17,19,21 As far as the 
training and education of health care providers is concerned, 
structured processes of scenario development/planning 
have proved useful in training future professionals to use an 
evidence-based approach in clinical decision-making.45 These 
could be applied in contexts where clinical inertia arises.
As summarized in a recent publication by Reach, clinical 
inaction may be called true clinical inertia only if: a recom-
mendation exists; the provider knows the recommendation; 
the provider believes the recommendation applies to the 
patient; the provider has the necessary resources to apply 
the recommendation; the provider does not apply the rec-
ommendation for a particular patient, even though the four 
aforementioned conditions are present.46 The first condition, 
ie, the need for a recommendation, points to an important 
factor of clinical inaction that tends to be overlooked in the 
literature, ie, that of possible gaps, lack of clarity, or dis-
crepancies in existing guidelines. In a search for common 
evidence-based quality indicators for type 2 diabetes care in 
practice guidelines across six European countries, Wens et al 
identified no fewer than 125 diabetes-related guidelines, of 
which only 81 (64.8%) met the necessary inclusion criteria 
to be considered for systematic review.47 In their discussion, 
these authors pointed to the fact that guidelines do not always 
specifically include evidence-based indicators, that they fail 
to reflect all aspects of care, and that they rarely refer to the 
newest treatment or management options as a result of lack 
of supporting evidence. In conclusion, they advocate further 
systematic development of “internationally best evidence-
based” indicators and guidelines to better inform practice.
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